Literature DB >> 6571696

Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27.

N Itoh, K Obata, N Yanaihara, H Okamoto.   

Abstract

Vasoactive intestinal polypeptide (VIP), a 28-amino acid peptide originally isolated from porcine duodenum, is present not only in gastrointestinal tissues but also in neural tissues, possibly as a neurotransmitter, and exhibits a wide range of biological actions (for example, relaxation of smooth muscle, stimulation of intestinal water and electrolyte secretion and release of insulin, glucagon and several anterior pituitary hormones). As the structure of porcine and bovine VIP shows several similarities to those of mammalian glucagon, secretin and gastric inhibitory peptide (GIP), VIP is considered to be a member of the glucagon-secretin family. Recently, we have found that VIP is synthesized from a precursor, pro-VIP (molecular weight (Mr) 17,500), in human neuroblastoma cells and that the primary translation product of the mRNA encoding VIP is prepro-VIP (Mr 20,000). In an attempt to elucidate the primary structure of the precursor, we have now cloned the DNA sequence complementary to the mRNA coding for human VIP and analysed the nucleotide sequence. The entire amino acid sequence of the precursor, deduced from the nucleotide sequence, indicates that the precursor protein contains not only VIP but also a novel peptide of 27 amino acids. The peptide, designated PHM-27, differs by only 2 amino acids from PHI-27, a peptide recently isolated from porcine intestine, and is also closely related in sequence to VIP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6571696     DOI: 10.1038/304547a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  68 in total

1.  Isolation and amino acid sequences of opossum vasoactive intestinal polypeptide and cholecystokinin octapeptide.

Authors:  J Eng; J Yu; S Rattan; R S Yalow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

Review 2.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Excitatory actions of peptide histidine isoleucine on thalamic relay neurons.

Authors:  Sang-Hun Lee; Charles L Cox
Journal:  Neuropharmacology       Date:  2008-08-30       Impact factor: 5.250

4.  Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.

Authors:  T R Koch; S R Michener; J A Carney; V L Go
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

Review 5.  Gene transfer into the nervous system.

Authors:  X O Breakefield; A I Geller
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

Review 6.  Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones.

Authors:  Amosy E M'Koma; Paul E Wise; Roberta L Muldoon; David A Schwartz; Mary K Washington; Alan J Herline
Journal:  Int J Colorectal Dis       Date:  2007-06-19       Impact factor: 2.571

7.  Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans.

Authors:  Lee Ann T Bennett; John M Johnson; Dan P Stephens; Adham R Saad; Dean L Kellogg
Journal:  J Physiol       Date:  2003-07-07       Impact factor: 5.182

8.  Existence and coexistence of peptides in nerves of the mammalian ovary and oviduct demonstrated by immunocytochemistry.

Authors:  P Kannisto; E Ekblad; G Helm; C Owman; N O Sjöberg; M Stjernquist; F Sundler; B Walles
Journal:  Histochemistry       Date:  1986

Review 9.  Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.

Authors:  S G R Smalley; P A Barrow; N Foster
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

10.  Effect of infused vasoactive intestinal peptide on airway function in normal subjects.

Authors:  J B Palmer; F M Cuss; J B Warren; M Blank; S R Bloom; P J Barnes
Journal:  Thorax       Date:  1986-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.